Riskpilot← Back to searchSign inGet full accessSOT Pharma AB
ABDissolvedOrg 5569270639Economic activity was not specified by tax authority · NACE 0000Est. 20130 employees
Revenue 2023
SEK 0
EBITDA margin
—
-15% vs 2022
Equity ratio
99.6%
Financial strength
Net profit 2023
SEK 114K
+1819% vs 2022
| Revenue | SEK 0 | — |
| EBITDA | SEK -8K | -15% |
| Net profit | SEK 114K | +1819% |
| Total assets | SEK 1,4M | +9% |
| Equity | SEK 1,4M | +9% |
| Employees | 0 | — |
Legal name
SOT Pharma AB
Org number
5569270639
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
26 mars 2013
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets verksamhet omfattar kapital- och värdepappersförvaltning samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — |
| EBITDA | −26 | −9 | −19 | −16 | −15 | −10 | −4 | −7 | −8 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | — |
| EBIT | −26 | −9 | −19 | −16 | −15 | −10 | −4 | −7 | −8 |
| Net financials | — | — | 15 010 | −1 679 | — | — | — | — | — |
| Profit before tax | −26 | −9 | 14 991 | −1 695 | −15 | −10 | −4 | −7 | 114 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | — |
| Net profit | −26 | −9 | 14 991 | −1 695 | −15 | −10 | −4 | −7 | 114 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 841 | 2 832 | 18 096 | 13 311 | 3 294 | 3 285 | 2 483 | 1 251 | 1 364 |
| Equity | −6 | −15 | 14 976 | 13 280 | 1 265 | 1 255 | 1 251 | 1 245 | 1 358 |
| Long-term debt | 1 000 | 1 000 | 0 | 0 | 2 021 | 2 021 | 1 225 | 0 | — |
| Short-term debt | 1 847 | 1 847 | 3 120 | 31 | 8 | 8 | 6 | 6 | 6 |
| Total debt | 2 847 | 2 847 | 3 120 | 31 | 2 029 | 2 029 | 1 231 | 6 | 6 |
EBITDA margin
-761500.0%
This company
15.8%
Market median
-4819720% vs market
20152023
Equity ratio
99.6%
This company
38.2%
Market median
+161% vs market
20152023
Return on equity
8.4%
This company
18.4%
Market median
-54% vs market
20152023
Net profit margin
11368500.0%
This company
8.1%
Market median
+140351752% vs market
20152023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152023
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20152023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Asango Growth AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Asango Growth AB
SOT Pharma AB Board members of SOT Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jörgen Asango Bladh | Board of Directors | 0 companies |
| Karl Jonas Thörnholm | Chairman | 0 companies |
| Lars Magnus Bladh | Deputy Board Member | 0 companies |